HALO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Halozyme Therapeutics (HALO) Earnings Date & Reports

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

HALO is expected to report earnings to fall 24.02% to 95 cents per share on May 13

Halozyme Therapeutics HALO Stock Earnings Reports

Q1'25

Est.

$0.96

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.31

Q2'24

Beat

by $0.15

Q1'24

Beat

by $0.10

The last earnings report on February 18 showed earnings per share of $1.26, beating the estimate of $1.15. With 686.04K shares outstanding, the current market capitalization sits at 7.79B.

View a ticker or compare two or three

Compare

HALO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For HALO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for HALO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12390 El Camino Real

Phone

+1 858 794-8889

Employees

373

Web

https://www.halozyme.com